News
ICViewExpert PerspectivesMedical World NewsPathogen PlaybookVideosWebinars
Conference CoverageConference ListingAPIC Chapters
Infection Control TodaySupplements And Featured Publications
CME/CEEditorial Advisory BoardJob BoardPartnersSponsoredWhitepapers
Subscribe
Educator of the Year Official Rules2024 Educator of the Year Winner2023 Educator of the Year WinnerEducator of the Year
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
Spotlight -
  • IC Trends
  • Bug of the Month
  • Featured Articles
  • Featured Columns
  • Pathogen Playbook
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
    • News
    • Subscribe
Advertisement

CDC Researchers Link Cancer Cells From Parasite to Human Tumors

November 4, 2015
Article

Scientists at the Centers for Disease Control and Prevention have discovered cancer cells originating in a common tapeworm may take root in people with weakened immune systems, causing cancer-like tumors. It is the first known case of a person becoming ill from cancer cells that arose in a parasite – in this case, Hymenolepis nana, the dwarf tapeworm.

The report, in the Nov. 5 issue of the New England Journal of Medicine, raises concern that other similar cases, if they occur, may be misdiagnosed as human cancer – especially in less developed countries where this tapeworm and immune-system-suppressing illnesses like HIV are widespread.

“We were amazed when we found this new type of disease – tapeworms growing inside a person essentially getting cancer that spreads to the person, causing tumors,” says Atis Muehlenbachs, MD, PhD, staff pathologist in CDC’s Infectious Diseases Pathology Branch (IDPB) and lead author of the study. “We think this type of event is rare. However, this tapeworm is found worldwide and millions of people globally suffer from conditions like HIV that weaken their immune system. So there may be more cases that are unrecognized. It’s definitely an area that deserves more study.”

In 2013, doctors in Colombia asked CDC to help diagnose bizarre biopsies from lung tumors and lymph nodes of a 41-year-old man who was HIV positive. The tumors looked similar to a human cancer, but initial CDC lab studies revealed the cancer-like cells were not human. That revelation kicked off a nearly three-year hunt for the cause of the man’s illness.

Researchers with IDPB, the CDC unit dedicated to investigating cases of unexplained illness and death, initially questioned whether it was an unusual cancer or an unknown infection. The growth pattern was decidedly cancer like, with too many cells crowded into small spaces and quickly multiplying. But the cells were tiny – about 10 times smaller than a normal human cancer cell. The researchers also noticed cells fusing together, which is rare for human cells.

They doggedly kept researching – performing dozens of tests – before eventually finding DNA from H. nana tapeworms in the man’s tumor in mid-2013. Unfortunately, the man died 72 hours later.

Figuring out how to help a patient who suffers from a similar ailment could be tricky for doctors – drugs to treat tapeworm infections may not be effective against tapeworm cancer cells in people. It is not clear whether human cancer treatments would help, although researchers think they might be beneficial. Physicians in developing nations should be aware of the possibility of similar illnesses, especially if they have patients with weakened immune systems who have tumors.

H. nana infects up to 75 million people at any given time, making it the most common tapeworm infection in humans. People get the tapeworm by eating food contaminated with mouse droppings or insects or by ingesting feces from someone else who is infected. Children are most often affected. Most people show no symptoms. However, in people whose immune systems are weak, including people who have HIV or are taking steroids, the tapeworm thrives.

Some 3,000 kinds of tapeworms are known to infect animals. But H. nana is the only one that can complete its entire lifecycle from egg to adult tapeworm within an individual’s small intestine. This can lead to large numbers of H. nana in the intestine, especially in people with weakened immune systems whose bodies have a harder time fighting the parasite. Researchers theorize that the mechanism that allows parasites like H. nana to avoid human immune systems may also have allowed the tapeworm’s cells to proliferate unchecked in the Colombian man.

H. nana infection is most common in areas where sanitation and handwashing are challenging. When traveling in less developed areas, people should protect themselves by washing their hands with soap and warm water and by washing, peeling, or cooking all raw vegetables and fruits with safe water before eating.

The study investigated tapeworms from the collections of the Natural History Museum in London. Peter D. Olson, PhD, a researcher and tapeworm expert at the Natural History Museum in London, provided information about the worms’ genetic data and helped interpret results. He says, “This study is an example of natural history and public health experts working together to uncover fascinating new details about the natural world. It represents an enormous advance in our knowledge and raises questions about the conditions under which cells may become cancerous.”

Source: CDC

Recent Videos
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Concept images of Far-UVC  (Adobe Stock 316993517 by hopenv)
Related Content

ACIP decides on vaccinations   (Adobe Stock 606491608 by N Lawrenson/peopleimages.com)

New ACIP Panel Backs Seasonal Flu, RSV Vaccinations, but Divisions Emerge Over Thimerosal and Infant Dosing

Richard Payerchin
June 27th 2025
Article

In its first major session under newly appointed leadership, the revamped Advisory Committee on Immunization Practices (ACIP) voted to support flu and RSV vaccinations for the 2025–2026 season, but internal debate over vaccine preservatives, access equity, and risk assessment highlighted the ideological and scientific tensions now shaping federal vaccine policy.


US Department of Health and Human Services

A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides

Richard Payerchin
June 26th 2025
Article

As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.


Jill Holdsworth, CIC, FAPIC, NREMT, CRCST, CHL; and Katie Belski, BSHCA, CRCST, CHL, CIS, CER, At HSPA25

Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski

Betsy Donahue, MA
June 26th 2025
Article

In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.


Infection Control Today's Hot Topics in IPC

Hot Topics for IPC for June 25, 2025: The Future of ACIP, Measles, and More

Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC
June 25th 2025
Article

This Hot Topics for IPC covers the latest on ACIP, vaccines, and a study on contact precautions for MRSA.


Infection prevention personnel in a training class.   (Adobe Stock 1196827000 by Carlo)

A Profession Without a Path: Reforming Infection Prevention and Control Education and Workforce Development

Shahbaz Salehi, MD, MPH, MSHIA;Anna Arifin, MD, MBA, MT, CIC
June 20th 2025
Article

Despite its critical role in patient safety, infection prevention and control (IPC) remains one of health care’s most misunderstood and understructured professions. While COVID-19 thrust IPC into the spotlight, the field still lacks a clear entry path, standardized training, and broad institutional recognition, leaving many professionals to learn on the job with minimal guidance.


Dr Erin Allmann Updyke and Erin Welsh, co-hosts of “This Podcast Will Kill You.”  (Image credit: author)

Combating Contagion, Confusion, and Public Mistrust: The Infection Preventionist’s Role in the Infodemic Era

Carole W. Kamangu, MPH, RN, CIC
June 19th 2025
Article

Infection preventionists are at the forefront of the infodemic; the keynote session offered suggestions on how they can combat and mitigate misinformation.

Related Content

ACIP decides on vaccinations   (Adobe Stock 606491608 by N Lawrenson/peopleimages.com)

New ACIP Panel Backs Seasonal Flu, RSV Vaccinations, but Divisions Emerge Over Thimerosal and Infant Dosing

Richard Payerchin
June 27th 2025
Article

In its first major session under newly appointed leadership, the revamped Advisory Committee on Immunization Practices (ACIP) voted to support flu and RSV vaccinations for the 2025–2026 season, but internal debate over vaccine preservatives, access equity, and risk assessment highlighted the ideological and scientific tensions now shaping federal vaccine policy.


US Department of Health and Human Services

A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides

Richard Payerchin
June 26th 2025
Article

As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.


Jill Holdsworth, CIC, FAPIC, NREMT, CRCST, CHL; and Katie Belski, BSHCA, CRCST, CHL, CIS, CER, At HSPA25

Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski

Betsy Donahue, MA
June 26th 2025
Article

In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.


Infection Control Today's Hot Topics in IPC

Hot Topics for IPC for June 25, 2025: The Future of ACIP, Measles, and More

Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC
June 25th 2025
Article

This Hot Topics for IPC covers the latest on ACIP, vaccines, and a study on contact precautions for MRSA.


Infection prevention personnel in a training class.   (Adobe Stock 1196827000 by Carlo)

A Profession Without a Path: Reforming Infection Prevention and Control Education and Workforce Development

Shahbaz Salehi, MD, MPH, MSHIA;Anna Arifin, MD, MBA, MT, CIC
June 20th 2025
Article

Despite its critical role in patient safety, infection prevention and control (IPC) remains one of health care’s most misunderstood and understructured professions. While COVID-19 thrust IPC into the spotlight, the field still lacks a clear entry path, standardized training, and broad institutional recognition, leaving many professionals to learn on the job with minimal guidance.


Dr Erin Allmann Updyke and Erin Welsh, co-hosts of “This Podcast Will Kill You.”  (Image credit: author)

Combating Contagion, Confusion, and Public Mistrust: The Infection Preventionist’s Role in the Infodemic Era

Carole W. Kamangu, MPH, RN, CIC
June 19th 2025
Article

Infection preventionists are at the forefront of the infodemic; the keynote session offered suggestions on how they can combat and mitigate misinformation.

Advertise
About Us
Editorial Board
Contact Us
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News